Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer (Liquid Biopsy)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jean Charles Soria, MD-PhD
- Phone Number: +33 0142114291
- Email: soria@gustaveroussy.fr
Study Locations
-
-
Val de Marne
-
Villejuif, Val de Marne, France, 94805
- Recruiting
- Gustave Roussy Cancer Campus Grand Paris
-
Contact:
- Jean Charles Soria, MD-PhD
- Phone Number: +33 0142114291
- Email: soria@gustaveroussy.fr
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with metastatic solid tumor
- Age> 18 years
- Signed consent
Exclusion Criteria:
- Patients with diseases associated with vascular lesions known.
- Patients protected by law, in accordance with Articles L1121-5 to L1121-8 of the Code of Public Health.
- Mental pathology that can interfere with the proper conduct of the study.
- Refusal of consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Other: Patients with metastatic cancer
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement and characterization of CEC and CEP and circulaing DNA rate using flow cytometry
Time Frame: up to 2 years
|
Measurement and characterization of initial CEC and CEP circulaing DNA and their evolution under treatment
|
up to 2 years
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Jean Charles Soria, MD-PhD, Gustave Roussy Cancer Campus
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2008-A00585-50
- 2008/1370 (Other Identifier: CSET number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.